For in vivo experiments, AMD3100 (10 mg/kg) was intraperitoneally injected into mice at 24 and 12 h before infection. After intravenous infection of sporozoites, mice were injected with AMD3100 at 0, 12, and 24 h after infection. According to the manufacturer’s protocol for AMD3100 (also known as Plerixafor; Genzyme Plerixafor Injection Investigator's Brochure, 2009, version 13, May 27, 2009), a half-life of AMD3100 was previously shown to be ∼5–6 h. Also, the manufacturer reported that the effect of AMD3100 in vivo continues four half-life times (∼20–24 h). In addition, our preliminary experiments to test how often normal mice can be treated with AMD3100 suggested that mice treated with AMD3100 (10 mg/kg) every 6 h become unhealthy. Therefore, we decided to administer AMD3100 treatment in mice every 12 h; treatments were performed at 24 h and 12 h before infection and at 0 h, 12 h, and 24 h after infection.
Amd3100
AMD3100 is a small molecule that functions as a CXCR4 antagonist. It is used as a laboratory research tool to study the CXCR4 chemokine receptor and its role in various biological processes.
3 protocols using amd3100
Inhibiting Malaria Sporozoite Infection
For in vivo experiments, AMD3100 (10 mg/kg) was intraperitoneally injected into mice at 24 and 12 h before infection. After intravenous infection of sporozoites, mice were injected with AMD3100 at 0, 12, and 24 h after infection. According to the manufacturer’s protocol for AMD3100 (also known as Plerixafor; Genzyme Plerixafor Injection Investigator's Brochure, 2009, version 13, May 27, 2009), a half-life of AMD3100 was previously shown to be ∼5–6 h. Also, the manufacturer reported that the effect of AMD3100 in vivo continues four half-life times (∼20–24 h). In addition, our preliminary experiments to test how often normal mice can be treated with AMD3100 suggested that mice treated with AMD3100 (10 mg/kg) every 6 h become unhealthy. Therefore, we decided to administer AMD3100 treatment in mice every 12 h; treatments were performed at 24 h and 12 h before infection and at 0 h, 12 h, and 24 h after infection.
Mobilization and Transplantation of Hematopoietic Stem Cells
Mobilizing Stem Cells for Transplantation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!